An increasing number of studies are describing potential uses of circulating tumour DNA
(ctDNA) in the care of patients with colorectal cancer. Owing to this rapidly develo** area …

Colorectal carcinoma is one of the most common cancers and one of the leading causes of
cancer-related death in the United States. Pathologic examination of biopsy, polypectomy …

PURPOSE To develop recommendations for adjuvant therapy for patients with resected
stage II colon cancer. METHODS ASCO convened an Expert Panel to conduct a systematic …

BACKGROUND: The safety and short-term benefits of laparoscopic colectomy for cancer
remain debatable. The multicentre COLOR (COlon cancer Laparoscopic or Open Resection) …

Abstract Background: The recently revised American Joint Committee on Cancer (AJCC)
sixth edition cancer staging system increased the stratification within colon cancer stages II …

BACKGROUND: Laparoscopic surgery for colon cancer has been proven safe, but debate
continues over whether the available long-term survival data justify implementation of …

Background: Oncologic resection techniques affect outcome for colon cancer and rectal
cancer, but standardized guidelines have not been adopted. The National Cancer Institute …

Purpose To address whether all medically fit patients with curatively resected stage II colon
cancer should be offered adjuvant chemotherapy as part of routine clinical practice, to …

Purpose The prognosis of patients with colorectal cancer has sometimes proved uncertain;
thus, the prognostic significance of immune criteria was compared with that of the tumor …

The prognostication of colorectal cancer (CRC) has traditionally relied on staging as defined
by the Union for International Cancer Control (UICC) and American Joint Committee on …